Seiichi Mori

Epithelial‐mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients

Tuan Zea Tan, Qing Hao Miow, Yoshio Miki et al. · EMBO Molecular Medicine · 2014 · 861 citations · Full text

Epithelial-mesenchymal Transition, Tumor Biology, Drug Responses +11

Development of peripheral lymphoid organs and natural killer cells depends on the helix–loop–helix inhibitor Id2

Yoshifumi Yokota, Ahmed Mansouri, Seiichi Mori et al. · Nature · 1999 · 834 citations

Lymphoid Neoplasia, Natural Killer Cells, Helix–loop–helix Inhibitor Id2 +12

Evidence for ecology's role in speciation

Jeffrey S. McKinnon, Seiichi Mori, Benjamin K. Blackman et al. · Nature · 2004 · 474 citations

Biodiversity, Molecular Evolutionary Ecology, Molecular Ecology +4

Hexasulfonated calix[6]arene derivatives: a new class of catalysts, surfactants, and host molecules

Seiji Shinkai, Seiichi Mori, Hiroshi Koreishi et al. · Journal of the American Chemical Society · 1986 · 465 citations

Engineering, Chemical Analysis, Altmetric Attention Score +16

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)

Ruby Yun‐Ju Huang, M. K. Wong, Tuan Zea Tan et al. · Cell Death and Disease · 2013 · 464 citations · Full text